Cargando…

Contribution of Inhibitor of DNA Binding/Differentiation-3 and Endocrine Disrupting Chemicals to Pathophysiological Aspects of Chronic Disease

The overwhelming increase in the global incidence of obesity and its associated complications such as insulin resistance, atherosclerosis, pulmonary disease, and degenerative disorders including dementia constitutes a serious public health problem. The Inhibitor of DNA Binding/Differentiation-3 (ID3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avecilla, Vincent, Doke, Mayur, Felty, Quentin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530454/ https://www.ncbi.nlm.nih.gov/pubmed/28785583 http://dx.doi.org/10.1155/2017/6307109

Ejemplares similares

Inhibitor of Differentiation-3 and Estrogenic Endocrine Disruptors: Implications for Susceptibility to Obesity and Metabolic Disorders
por: Doke, Mayur, et al.
Publicado: (2018)

Contribution of Inhibitor of Differentiation and Estrogenic Endocrine Disruptors to Neurocognitive Disorders
por: Avecilla, Andrea, et al.
Publicado: (2018)

Endocrine Disrupting Chemicals Influence Hub Genes Associated with Aggressive Prostate Cancer
por: Alwadi, Diaaidden, et al.
Publicado: (2023)

Inhibitor of DNA-Binding/Differentiation Proteins and Environmental Toxicants: Genomic Impact on the Onset of Depressive Dysfunction
por: Avecilla, Vincent, et al.
Publicado: (2019)

Endocrine Disrupting Chemicals: Effects on Endocrine Glands
por: Lauretta, Rosa, et al.
Publicado: (2019)

Endocrine-Disrupting Chemicals and Infectious Diseases: From Endocrine Disruption to Immunosuppression
por: Adegoke, Elikanah Olusayo, et al.
Publicado: (2021)

Obesity and endocrine-disrupting chemicals
por: Amato, Angelica Amorim, et al.
Publicado: (2021)

Chemical communication threatened by endocrine-disrupting chemicals.
por: Fox, Jennifer E
Publicado: (2004)

Circadian disruption and psychostimulants dysregulates plasma acute-phase proteins and circulating cell-free mitochondrial DNA
por: Ramasamy, Tamizhselvi, et al.
Publicado: (2023)

The challenge posed by endocrine-disrupting chemicals.
por: Ashby, J, et al.
Publicado: (1997)

Childhood obesity and endocrine disrupting chemicals
por: Kim, Jin Taek, et al.
Publicado: (2017)

Endocrine-Disrupting Chemicals and Disease Endpoints
por: Ahn, Changhwan, et al.
Publicado: (2023)

Estrogen-induced DNA synthesis in vascular endothelial cells is mediated by ROS signaling
por: Felty, Quentin
Publicado: (2006)

Endocrine Disrupting Chemicals Mediated through Binding Androgen Receptor Are Associated with Diabetes Mellitus
por: Sakkiah, Sugunadevi, et al.
Publicado: (2017)

Cognitive effects of endocrine-disrupting chemicals in animals.
por: Schantz, S L, et al.
Publicado: (2001)

Endocrine-Disrupting Chemicals and Insulin Resistance in Children
por: Rotondo, Eleonora, et al.
Publicado: (2020)

Endocrine Disrupting Chemicals and Type 1 Diabetes
por: Predieri, Barbara, et al.
Publicado: (2020)

Endocrine‐disrupting chemicals and male reproductive health
por: Sharma, Aditi, et al.
Publicado: (2020)

Endocrine-Disrupting Chemicals in Human Fetal Growth
por: Street, Maria Elisabeth, et al.
Publicado: (2020)

Endocrine Disrupting Chemicals and Thyroid Cancer: An Overview
por: Alsen, Mathilda, et al.
Publicado: (2021)

Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Obesity
por: Nettore, Immacolata Cristina, et al.
Publicado: (2021)

Endocrine-Disrupting Chemicals and Early Puberty in Girls
por: Papadimitriou, Anastasios, et al.
Publicado: (2021)

The effect of endocrine-disrupting chemicals on placental development
por: Yan, Yan, et al.
Publicado: (2023)

PCB153-Induced Overexpression of ID3 Contributes to the Development of Microvascular Lesions
por: Das, Jayanta K., et al.
Publicado: (2014)

Phytoestrogen signaling and symbiotic gene activation are disrupted by endocrine-disrupting chemicals.
por: Fox, Jennifer E, et al.
Publicado: (2004)

Modelling the interaction of steroid receptors with endocrine disrupting chemicals
por: D'Ursi, Pasqualina, et al.
Publicado: (2005)

Developmental effects of endocrine-disrupting chemicals in wildlife and humans.
por: Colborn, T, et al.
Publicado: (1993)

The EDKB: an established knowledge base for endocrine disrupting chemicals
por: Ding, Don, et al.
Publicado: (2010)

Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action
por: De Coster, Sam, et al.
Publicado: (2012)

Endocrine disrupting chemicals and the growth of environmental health in Israel
por: Falk, Henry
Publicado: (2012)

Exposure to Endocrine Disrupting Chemicals and Male Reproductive Health
por: Jeng, Hueiwang Anna
Publicado: (2014)

Endocrine disrupting chemicals and impact on male reproductive health
por: Rehman, Saba, et al.
Publicado: (2018)

Symbiotic Gene Activation is Interrupted by Endocrine Disrupting Chemicals
por: Fox, Jennifer E., et al.
Publicado: (2001)

Endocrine Disrupting Chemicals: An Occult Mediator of Metabolic Disease
por: Papalou, Olga, et al.
Publicado: (2019)

GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs)
por: Périan, Séverine, et al.
Publicado: (2020)

Nonpersistent endocrine disrupting chemicals and reproductive health of women
por: Cho, Yeon Jean, et al.
Publicado: (2020)

Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer
por: Eve, Louisane, et al.
Publicado: (2020)

Endocrine Disrupting Chemicals and Reproductive Health in Boys and Men
por: Rodprasert, Wiwat, et al.
Publicado: (2021)

Endocrine-Disrupting Chemicals and Their Adverse Effects on the Endoplasmic Reticulum
por: Kim, Kangmin, et al.
Publicado: (2022)

Health Effects Associated with Exposures to Endocrine Disrupting Chemicals
por: Toft, Gunnar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o9vfgg3vc0uj9rcveeqop222i7